Pelkmans, Wiesje;
Shekari, Mahnaz;
Brugulat-Serrat, Anna;
Sánchez-Benavides, Gonzalo;
Minguillón, Carolina;
Fauria, Karine;
Molinuevo, Jose Luis;
... ALFA study, .; + view all
(2023)
Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.
Alzheimer's & Dementia
10.1002/alz.13450.
(In press).
Preview |
PDF
Alzheimer s Dementia - 2023 - Pelkmans.pdf - Published Version Download (1MB) | Preview |
Abstract
INTRODUCTION: We studied how biomarkers of reactive astrogliosis mediate the pathogenic cascade in the earliest Alzheimer's disease (AD) stages.// METHODS: We performed path analysis on data from 384 cognitively unimpaired individuals from the ALzheimer and FAmilies (ALFA)+ study using structural equation modeling to quantify the relationships between biomarkers of reactive astrogliosis and the AD pathological cascade.// RESULTS: Cerebrospinal fluid (CSF) amyloid beta (Aβ)42/40 was associated with Aβ aggregation on positron emission tomography (PET) and with CSF p-tau181, which was in turn directly associated with CSF neurofilament light (NfL). Plasma glial fibrillary acidic protein (GFAP) mediated the relationship between CSF Aβ42/40 and Aβ-PET, and CSF YKL-40 partly explained the association between Aβ-PET, p-tau181, and NfL.// DISCUSSION: Our results suggest that reactive astrogliosis, as indicated by different fluid biomarkers, influences the pathogenic cascade during the preclinical stage of AD. While plasma GFAP mediates the early association between soluble and insoluble Aβ, CSF YKL-40 mediates the latter association between Aβ and downstream Aβ-induced tau pathology and tau-induced neuronal injury.
| Type: | Article |
|---|---|
| Title: | Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1002/alz.13450 |
| Publisher version: | https://doi.org/10.1002/alz.13450 |
| Language: | English |
| Additional information: | © 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Keywords: | AD cascade, astrogliosis, biomarkers, chitinase-3-like protein 1 (YKL-40), glial fibrillary acidic protein (GFAP), preclinical Alzheimer's disease, structural equation modeling |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10177286 |
Archive Staff Only
 |
View Item |
